These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 20587495)
1. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours. Kim JW; Park CK; Park SH; Kim YH; Han JH; Kim CY; Sohn CH; Chang KH; Jung HW J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):224-7. PubMed ID: 20587495 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. Kouwenhoven MC; Gorlia T; Kros JM; Ibdaih A; Brandes AA; Bromberg JE; Mokhtari K; van Duinen SG; Teepen JL; Wesseling P; Vandenbos F; Grisold W; Sipos L; Mirimanoff R; Vecht CJ; Allgeier A; Lacombe D; van den Bent MJ Neuro Oncol; 2009 Dec; 11(6):737-46. PubMed ID: 19224764 [TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
4. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas. Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623 [TBL] [Abstract][Full Text] [Related]
6. 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas. Jiang H; Ren X; Cui X; Wang J; Jia W; Zhou Z; Lin S Neuro Oncol; 2013 Jun; 15(6):775-82. PubMed ID: 23486687 [TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
8. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors]. Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors. Chamberlain MC; Born D J Neurooncol; 2015 Nov; 125(2):249-51. PubMed ID: 26341371 [TBL] [Abstract][Full Text] [Related]
10. Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients. Wang K; Wang Y; Fan X; Li Y; Liu X; Wang J; Ai L; Dai J; Jiang T J Neurooncol; 2018 Feb; 136(3):523-531. PubMed ID: 29230668 [TBL] [Abstract][Full Text] [Related]
11. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Jenkinson MD; du Plessis DG; Smith TS; Joyce KA; Warnke PC; Walker C Brain; 2006 Jul; 129(Pt 7):1884-91. PubMed ID: 16670176 [TBL] [Abstract][Full Text] [Related]
12. Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report. Takami H; Mukasa A; Takayanagi S; Koike T; Matsuura R; Ikemura M; Ushiku T; Yoshikawa G; Shibahara J; Tanaka S; Saito N Brain Tumor Pathol; 2023 Jan; 40(1):26-34. PubMed ID: 36572828 [TBL] [Abstract][Full Text] [Related]
13. Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion. Pai T; Epari S; Desai S; Wadile A; Gupta T; Goda JS; Moiyadi A; Shetty P; Kane S; Jalali R Neurol India; 2017; 65(1):113-120. PubMed ID: 28084254 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]. Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359 [TBL] [Abstract][Full Text] [Related]
16. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma. Sathornsumetee S; Cheunsuchon P; Sangruchi T World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282 [TBL] [Abstract][Full Text] [Related]
17. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A; Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167 [TBL] [Abstract][Full Text] [Related]
18. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340 [TBL] [Abstract][Full Text] [Related]
19. 1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma. Andrews C; Prayson RA Ann Diagn Pathol; 2020 Jun; 46():151519. PubMed ID: 32305004 [TBL] [Abstract][Full Text] [Related]